News
CardioComm Solutions, Inc. (CardioComm Solutions) (TSX VENTURE:EKG)
completed a recent interview with the Wall Street Reporter and an
upcoming Ad in USA Today mark the beginning of a Marketing
Communications Campaign in support of the company' entry into the
Health Market with their recently announced Food and Drug
Administration (FDA) clear HeartCheck Pen Hand Held ECG targeted at
consumers.
In his interview with the Wall Street Reporter Mr. Etienne Grima, CEO,
discussed CardioComm Solution's current direction in the field of
Telemedicine and provided insight into planned initiatives that the
company will be launching over the next 24 months, initiatives
building on proven and stable software products. The interview
highlighted CardioComm Solutions as a software engineering company
that is not dependent on others for software enhancements and
innovations, a company emerging from three years of planning with an
aim to close the gap in providing access for patients and consumers to
qualified medical care.
Francois Paul Thibault, Canadian Designer and Sculpture of Yellow
Knife, NWT, Canada said, "I believe CardioComm's technology will
empower people with direct access to doctors and professional teams at
breakneck wireless internet speeds. This will streamline our health
system to where it should be and reach well beyond. CardioComm's new
wireless propriety software and HeartCheckTM PEN technology will allow
patients and individuals from all areas of the globe to save valuable
time. What CardioComm will offer is the opportunity to save millions
of dollars in medical travel services in regions like the NWT, the
Yukon and Nunavut. Each year hundreds of people fly escorted to large
centers for these types of test at an incredible cost to our
Government and Health Care system. Investing in one of these PEN
devices will save a world of uncertainties, alleviate sleepless nights
and most importantly may save a multitude of lives. Finally the Star
Trek Era is here."
CardioComm Solutions to Co Sponsor Publication for National Heart
Health Month
In keeping with their commitment to patient education and awareness,
CardioComm Solutions, Inc. will be co-sponsoring a major educational
publication and campaign for National Heart Health Month. On February
23rd, 2012, Mediaplanet Publishing, Inc. will be releasing its 5th
edition of "Cardiovascular Health" to be distributed in USA Today in
key regional markets. The publication will stress the importance of
open patient-doctor dialogue and will also address issues around
Atrial Fibrillation. "We thought this would be a great opportunity to
introduce the HeartCheckTM PEN to a consumer audience and discuss how
innovative patient monitoring can help prevent the occurrence of
sudden cardiac events," said Etienne Grima.
"CardioComm Solutions continues to be a significant player in ECG
Management Solutions," noted Mr. Simi Grosman, a member of CardioComm
Solution's Board of Directors, "under the stewardship of Dr. Anatoly
Langer, the company's Chairman of the Board, and CEO Etienne Grima's
business leadership and vision, the company is beginning to see the
results of the last 3 years of continuous product development and
software enhancements."
About CardioComm Solutions
CardioComm Solution's patented and proprietary technology is used in
products for recording, viewing, analyzing and storing
electrocardiograms (ECGs) for diagnosis and management of cardiac
patients. Products are sold worldwide through a combination of an
external distribution network and a North American-based sales team.
The company has earned the ISO 13485 certification, is HPB approved,
HIPAA compliant, and has received FDA market clearance for its
software devices. CardioComm Solutions, Inc. is headquartered in
Toronto, Canada, with offices in Victoria, B.C.
Forward-looking statements
This release may contain certain forward-looking statements with
respect to the financial condition, results of operations and business
of CardioComm Solutions and certain of the plans and objectives of
CardioComm Solutions with respect to these items. By their nature,
forward-looking statements involve risk and uncertainty because they
relate to events and depend on circumstances that will occur in the
future and there are many factors that could cause actual results and
developments to differ materially from those expressed or implied by
these forward-looking statements.
Neither TSX Venture Exchange nor its Regulation Services Provider (as
that term is defined in policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.
